Closed consultation

Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

This consultation ran from
to

Summary

MHRA is asking for feedback on proposals to change the legal classification of Otrivine extra dual relief nasal spray solution from prescription only medicine (POM) to pharmacy only (P).